XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 65,572 $ 146,256
Accounts receivable, net 20,920 14,657
Inventories 21,565 1,762
Prepaid expenses 3,656 5,082
Other current assets 4,233 11,042
Total current assets 115,946 178,799
Property and equipment, net 1,882 1,371
Operating lease right-of-use assets 2,149 2,722
Intangible assets, net 49,108 50,625
Goodwill 21,208 21,208
Other assets 2,426 2,758
Total assets 192,719 257,483
Current liabilities    
Accounts payable 8,564 6,091
Accrued expenses 29,883 29,993
Accrued litigation settlement 5,000 15,000
Operating lease liabilities 1,307 1,265
Contingent royalty obligation payable to Evolus Founders 6,517 5,314
Total current liabilities 51,271 57,663
Accrued litigation settlement 0 5,000
Operating lease liabilities 1,491 2,256
Contingent royalty obligation payable to Evolus Founders 39,000 39,426
Term loan, net of discounts and issuance costs 71,712 71,222
Deferred tax liability 25 40
Total liabilities 163,499 175,607
Commitments and contingencies (Note 9)
Stockholders’ equity    
Preferred stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 0 0
Common stock, $0.00001 par value; 100,000,000 shares authorized; 56,183,414 and 55,576,988 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 1 1
Additional paid-in capital 513,717 504,757
Accumulated other comprehensive loss (368) 0
Accumulated deficit (484,130) (422,882)
Total stockholders’ equity 29,220 81,876
Total liabilities and stockholders’ equity $ 192,719 $ 257,483